TrianglePUBLICATIONS · 31811016
Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Clin Cancer Res
- Publication date
- 2019 Dec 15
- First author
- Hargrave DR
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Hargrave DR
- type
- Author
- name
- Bouffet E
- type
- Author
- name
- Tabori U
- type
- Author
- name
- Broniscer A
- type
- Author
- name
- Cohen KJ
- type
- Author
- name
- Hansford JR
- type
- Author
- name
- Geoerger B
- type
- Author
- name
- Hingorani P
- type
- Author
- name
- Dunkel IJ
- type
- Author
- name
- Russo MW
- type
- Author
- name
- Tseng L
- type
- Author
- name
- Dasgupta K
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Hargrave DR
- type
- Author
- name
- Bouffet E
- type
- Author
- name
- Tabori U
- type
- Author
- name
- Broniscer A
- type
- Author
- name
- Cohen KJ
- type
- Author
- name
- Hansford JR
- type
- Author
- name
- Geoerger B
- type
- Author
- name
- Hingorani P
- type
- Author
- name
- Dunkel IJ
- type
- Author
- name
- Russo MW
- type
- Author
- name
- Tseng L
- type
- Author
- name
- Dasgupta K
- type
- Author
- bibliography ids
- nci-bib-8a5565c1dc9eaffa778f5664
- book metadata
- content sha256
- 000cba3777fc3df3432ea1a2b45717973b592da4432ca4884bf031f296bc77e6
- document type
- citation
- dois
- 10.1158/1078-0432.CCR-19-2177
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:31811016
- immutable id
- pubmed:31811016@000cba3777fc3df3432ea1a2b45717973b592da4432ca4884bf031f296bc77e6
- journal
- abbreviation
- Clin Cancer Res
- issn electronic
- 1557-3265
- issn print
- 1078-0432
- issue
- 24
- name
- Clinical cancer research : an official journal of the American Association for Cancer Research
- nlm unique id
- 9502500
- pages
- 7303-7311
- volume
- 25
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 31811016
- provenance
- batch id
- 4c5003fbb78890e89ae1
- provider
- NCBI PubMed ESummary
- record sha256
- 59a69e1418ad9442b0bbc4b0d9cc4abd4a15b0addb073ba454dc1dfd8aeee017
- response sha256
- 890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
- retrieved at
- 2026-09-09T23:47:48.270700+00:00
- publication date
- display
- 2019 Dec 15
- precision
- day
- year
- 2019
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, N.I.H., Extramural
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation-Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study.
Preserved source evidence · Not medical advice